Ostentus Therapeutics has entered into a Sponsored Research Agreement with City of Hope, a world-renowned cancer treatment and research organization and a National Cancer Institute-designated Comprehensive Cancer Center, to conduct preclinical research on OST compounds, which could be used as future therapies for leukemia and other cancers.
Dr. Marcucci’s lab at City of Hope will conduct Phase I and II (Milestone 1-4) of our research program.
Made with Mobirise